Stelexis BioSciences
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of STLX-2012 in Healthy Volunteers (NCT07231744) | Stelexis BioSciences | 2026-10-01 |
| Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML (NCT06533761) | Stelexis BioSciences | 2025-04-28 |
Track Stelexis BioSciences automatically
Every clearance here is in the API, with alerts when new ones post.